Report Cover

Global Amlodipine Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    by Product
        Amlodipine Benzene Sulfonate Tablet
        Amlodipine Mesylate Tablet
        Levoamlodipine Maleic Acid Tablet
    by Form
        Tablets
        Capsule

Segment by Application
    High Blood Pressure
    Angina Pectoris
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Novartis
    Pfizer
    Lek
    TEVA
    Macleods Pharmaceuticals
    Caraco Pharmaceutical
    Sanis Health
    Jamp Pharma
    Accel Pharma
    Jubilant Generics
    Angita Pharma
    Florida DOH Central Pharmacy
    Shanghai Disainuo Biopharmaceutical
    Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
    Beijing Wansheng Pharmaceutical
    Beijing Honglin Pharmaceutical
    Beijing Maidihai Pharmaceutical
    China Resources Saike Pharmaceutical
    Beijing Jiulong Pharmaceutical
    Tiannian Pharmaceutical
    Chengdu Diao Pharmaceutical Group
    Yangtze Pharmaceutical
    Kunming Sino Pharmaceutical
    Wuhan Dongxin Pharmaceutical Technology
    Jiangsu Wangao Pharmaceutical
    Jiangsu Lianhuan Pharmaceutical
    Jiangsu Huanghe Pharmaceutical
    Zhejiang Jingxin Pharmaceutical
    Zhejiang Jianfeng Pharmaceutical
    Hunan Qianjinxieli Pharmaceutical
1 Amlodipine Market Overview
    1.1 Product Overview and Scope of Amlodipine
    1.2 Amlodipine Segment by Product
        1.2.1 Global Amlodipine Sales Growth Rate Comparison by Product  (2021-2027)
        1.2.2 Amlodipine Benzene Sulfonate Tablet
        1.2.3 Amlodipine Mesylate Tablet
        1.2.4 Levoamlodipine Maleic Acid Tablet
    1.3 Amlodipine Segment by Application
        1.3.1 Amlodipine Sales Comparison by Application: (2021-2027)
        1.3.2 High Blood Pressure
        1.3.3 Angina Pectoris
        1.3.4 Other
    1.4 Global Amlodipine Market Size Estimates and Forecasts
        1.4.1 Global Amlodipine Revenue 2016-2027
        1.4.2 Global Amlodipine Sales 2016-2027
        1.4.3 Amlodipine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Amlodipine Market Competition by Manufacturers
    2.1 Global Amlodipine Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Amlodipine Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Amlodipine Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Amlodipine Manufacturing Sites, Area Served, Product Type
    2.5 Amlodipine Market Competitive Situation and Trends
        2.5.1 Amlodipine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Amlodipine Players Market Share by Revenue
        2.5.3 Global Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Amlodipine Retrospective Market Scenario by Region
    3.1 Global Amlodipine Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Amlodipine Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Amlodipine Market Facts & Figures by Country
        3.3.1 North America Amlodipine Sales by Country
        3.3.2 North America Amlodipine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Amlodipine Market Facts & Figures by Country
        3.4.1 Europe Amlodipine Sales by Country
        3.4.2 Europe Amlodipine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Amlodipine Market Facts & Figures by Region
        3.5.1 Asia Pacific Amlodipine Sales by Region
        3.5.2 Asia Pacific Amlodipine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Amlodipine Market Facts & Figures by Country
        3.6.1 Latin America Amlodipine Sales by Country
        3.6.2 Latin America Amlodipine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Amlodipine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Amlodipine Sales by Country
        3.7.2 Middle East and Africa Amlodipine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Amlodipine Historic Market Analysis by Type
    4.1 Global Amlodipine Sales Market Share by Type (2016-2021)
    4.2 Global Amlodipine Revenue Market Share by Type (2016-2021)
    4.3 Global Amlodipine Price by Type (2016-2021)

5 Global Amlodipine Historic Market Analysis by Application
    5.1 Global Amlodipine Sales Market Share by Application (2016-2021)
    5.2 Global Amlodipine Revenue Market Share by Application (2016-2021)
    5.3 Global Amlodipine Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Novartis
        6.1.1 Novartis Corporation Information
        6.1.2 Novartis Description and Business Overview
        6.1.3 Novartis Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Novartis Product Portfolio
        6.1.5 Novartis Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Pfizer Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Lek
        6.3.1 Lek Corporation Information
        6.3.2 Lek Description and Business Overview
        6.3.3 Lek Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Lek Product Portfolio
        6.3.5 Lek Recent Developments/Updates
    6.4 TEVA
        6.4.1 TEVA Corporation Information
        6.4.2 TEVA Description and Business Overview
        6.4.3 TEVA Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 TEVA Product Portfolio
        6.4.5 TEVA Recent Developments/Updates
    6.5 Macleods Pharmaceuticals
        6.5.1 Macleods Pharmaceuticals Corporation Information
        6.5.2 Macleods Pharmaceuticals Description and Business Overview
        6.5.3 Macleods Pharmaceuticals Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Macleods Pharmaceuticals Product Portfolio
        6.5.5 Macleods Pharmaceuticals Recent Developments/Updates
    6.6 Caraco Pharmaceutical
        6.6.1 Caraco Pharmaceutical Corporation Information
        6.6.2 Caraco Pharmaceutical Description and Business Overview
        6.6.3 Caraco Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Caraco Pharmaceutical Product Portfolio
        6.6.5 Caraco Pharmaceutical Recent Developments/Updates
    6.7 Sanis Health
        6.6.1 Sanis Health Corporation Information
        6.6.2 Sanis Health Description and Business Overview
        6.6.3 Sanis Health Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Sanis Health Product Portfolio
        6.7.5 Sanis Health Recent Developments/Updates
    6.8 Jamp Pharma
        6.8.1 Jamp Pharma Corporation Information
        6.8.2 Jamp Pharma Description and Business Overview
        6.8.3 Jamp Pharma Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Jamp Pharma Product Portfolio
        6.8.5 Jamp Pharma Recent Developments/Updates
    6.9 Accel Pharma
        6.9.1 Accel Pharma Corporation Information
        6.9.2 Accel Pharma Description and Business Overview
        6.9.3 Accel Pharma Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Accel Pharma Product Portfolio
        6.9.5 Accel Pharma Recent Developments/Updates
    6.10 Jubilant Generics
        6.10.1 Jubilant Generics Corporation Information
        6.10.2 Jubilant Generics Description and Business Overview
        6.10.3 Jubilant Generics Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Jubilant Generics Product Portfolio
        6.10.5 Jubilant Generics Recent Developments/Updates
    6.11 Angita Pharma
        6.11.1 Angita Pharma Corporation Information
        6.11.2 Angita Pharma Amlodipine Description and Business Overview
        6.11.3 Angita Pharma Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Angita Pharma Product Portfolio
        6.11.5 Angita Pharma Recent Developments/Updates
    6.12 Florida DOH Central Pharmacy
        6.12.1 Florida DOH Central Pharmacy Corporation Information
        6.12.2 Florida DOH Central Pharmacy Amlodipine Description and Business Overview
        6.12.3 Florida DOH Central Pharmacy Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Florida DOH Central Pharmacy Product Portfolio
        6.12.5 Florida DOH Central Pharmacy Recent Developments/Updates
    6.13 Shanghai Disainuo Biopharmaceutical
        6.13.1 Shanghai Disainuo Biopharmaceutical Corporation Information
        6.13.2 Shanghai Disainuo Biopharmaceutical Amlodipine Description and Business Overview
        6.13.3 Shanghai Disainuo Biopharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Shanghai Disainuo Biopharmaceutical Product Portfolio
        6.13.5 Shanghai Disainuo Biopharmaceutical Recent Developments/Updates
    6.14 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
        6.14.1 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Corporation Information
        6.14.2 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Description and Business Overview
        6.14.3 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Product Portfolio
        6.14.5 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Developments/Updates
    6.15 Beijing Wansheng Pharmaceutical
        6.15.1 Beijing Wansheng Pharmaceutical Corporation Information
        6.15.2 Beijing Wansheng Pharmaceutical Amlodipine Description and Business Overview
        6.15.3 Beijing Wansheng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Beijing Wansheng Pharmaceutical Product Portfolio
        6.15.5 Beijing Wansheng Pharmaceutical Recent Developments/Updates
    6.16 Beijing Honglin Pharmaceutical
        6.16.1 Beijing Honglin Pharmaceutical Corporation Information
        6.16.2 Beijing Honglin Pharmaceutical Amlodipine Description and Business Overview
        6.16.3 Beijing Honglin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Beijing Honglin Pharmaceutical Product Portfolio
        6.16.5 Beijing Honglin Pharmaceutical Recent Developments/Updates
    6.17 Beijing Maidihai Pharmaceutical
        6.17.1 Beijing Maidihai Pharmaceutical Corporation Information
        6.17.2 Beijing Maidihai Pharmaceutical Amlodipine Description and Business Overview
        6.17.3 Beijing Maidihai Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Beijing Maidihai Pharmaceutical Product Portfolio
        6.17.5 Beijing Maidihai Pharmaceutical Recent Developments/Updates
    6.18 China Resources Saike Pharmaceutical
        6.18.1 China Resources Saike Pharmaceutical Corporation Information
        6.18.2 China Resources Saike Pharmaceutical Amlodipine Description and Business Overview
        6.18.3 China Resources Saike Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 China Resources Saike Pharmaceutical Product Portfolio
        6.18.5 China Resources Saike Pharmaceutical Recent Developments/Updates
    6.19 Beijing Jiulong Pharmaceutical
        6.19.1 Beijing Jiulong Pharmaceutical Corporation Information
        6.19.2 Beijing Jiulong Pharmaceutical Amlodipine Description and Business Overview
        6.19.3 Beijing Jiulong Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Beijing Jiulong Pharmaceutical Product Portfolio
        6.19.5 Beijing Jiulong Pharmaceutical Recent Developments/Updates
    6.20 Tiannian Pharmaceutical
        6.20.1 Tiannian Pharmaceutical Corporation Information
        6.20.2 Tiannian Pharmaceutical Amlodipine Description and Business Overview
        6.20.3 Tiannian Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Tiannian Pharmaceutical Product Portfolio
        6.20.5 Tiannian Pharmaceutical Recent Developments/Updates
    6.21 Chengdu Diao Pharmaceutical Group
        6.21.1 Chengdu Diao Pharmaceutical Group Corporation Information
        6.21.2 Chengdu Diao Pharmaceutical Group Amlodipine Description and Business Overview
        6.21.3 Chengdu Diao Pharmaceutical Group Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Chengdu Diao Pharmaceutical Group Product Portfolio
        6.21.5 Chengdu Diao Pharmaceutical Group Recent Developments/Updates
    6.22 Yangtze Pharmaceutical
        6.22.1 Yangtze Pharmaceutical Corporation Information
        6.22.2 Yangtze Pharmaceutical Amlodipine Description and Business Overview
        6.22.3 Yangtze Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Yangtze Pharmaceutical Product Portfolio
        6.22.5 Yangtze Pharmaceutical Recent Developments/Updates
    6.23 Kunming Sino Pharmaceutical
        6.23.1 Kunming Sino Pharmaceutical Corporation Information
        6.23.2 Kunming Sino Pharmaceutical Amlodipine Description and Business Overview
        6.23.3 Kunming Sino Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Kunming Sino Pharmaceutical Product Portfolio
        6.23.5 Kunming Sino Pharmaceutical Recent Developments/Updates
    6.24 Wuhan Dongxin Pharmaceutical Technology
        6.24.1 Wuhan Dongxin Pharmaceutical Technology Corporation Information
        6.24.2 Wuhan Dongxin Pharmaceutical Technology Amlodipine Description and Business Overview
        6.24.3 Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Wuhan Dongxin Pharmaceutical Technology Product Portfolio
        6.24.5 Wuhan Dongxin Pharmaceutical Technology Recent Developments/Updates
    6.25 Jiangsu Wangao Pharmaceutical
        6.25.1 Jiangsu Wangao Pharmaceutical Corporation Information
        6.25.2 Jiangsu Wangao Pharmaceutical Amlodipine Description and Business Overview
        6.25.3 Jiangsu Wangao Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Jiangsu Wangao Pharmaceutical Product Portfolio
        6.25.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
    6.26 Jiangsu Lianhuan Pharmaceutical
        6.26.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
        6.26.2 Jiangsu Lianhuan Pharmaceutical Amlodipine Description and Business Overview
        6.26.3 Jiangsu Lianhuan Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Jiangsu Lianhuan Pharmaceutical Product Portfolio
        6.26.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
    6.27 Jiangsu Huanghe Pharmaceutical
        6.27.1 Jiangsu Huanghe Pharmaceutical Corporation Information
        6.27.2 Jiangsu Huanghe Pharmaceutical Amlodipine Description and Business Overview
        6.27.3 Jiangsu Huanghe Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.27.4 Jiangsu Huanghe Pharmaceutical Product Portfolio
        6.27.5 Jiangsu Huanghe Pharmaceutical Recent Developments/Updates
    6.28 Zhejiang Jingxin Pharmaceutical
        6.28.1 Zhejiang Jingxin Pharmaceutical Corporation Information
        6.28.2 Zhejiang Jingxin Pharmaceutical Amlodipine Description and Business Overview
        6.28.3 Zhejiang Jingxin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.28.4 Zhejiang Jingxin Pharmaceutical Product Portfolio
        6.28.5 Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
    6.29 Zhejiang Jianfeng Pharmaceutical
        6.29.1 Zhejiang Jianfeng Pharmaceutical Corporation Information
        6.29.2 Zhejiang Jianfeng Pharmaceutical Amlodipine Description and Business Overview
        6.29.3 Zhejiang Jianfeng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.29.4 Zhejiang Jianfeng Pharmaceutical Product Portfolio
        6.29.5 Zhejiang Jianfeng Pharmaceutical Recent Developments/Updates
    6.30 Hunan Qianjinxieli Pharmaceutical
        6.30.1 Hunan Qianjinxieli Pharmaceutical Corporation Information
        6.30.2 Hunan Qianjinxieli Pharmaceutical Amlodipine Description and Business Overview
        6.30.3 Hunan Qianjinxieli Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
        6.30.4 Hunan Qianjinxieli Pharmaceutical Product Portfolio
        6.30.5 Hunan Qianjinxieli Pharmaceutical Recent Developments/Updates

7 Amlodipine Manufacturing Cost Analysis
    7.1 Amlodipine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Amlodipine
    7.4 Amlodipine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Amlodipine Distributors List
    8.3 Amlodipine Customers

9 Amlodipine Market Dynamics
    9.1 Amlodipine Industry Trends
    9.2 Amlodipine Growth Drivers
    9.3 Amlodipine Market Challenges
    9.4 Amlodipine Market Restraints

10 Global Market Forecast
    10.1 Amlodipine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Amlodipine by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Amlodipine by Type (2022-2027)
    10.2 Amlodipine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Amlodipine by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Amlodipine by Application (2022-2027)
    10.3 Amlodipine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Amlodipine by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Amlodipine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Amlodipine Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Amlodipine Sales (KG) Comparison by Application (2021-2027) Table 3. Global Amlodipine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Amlodipine Covered in This Study Table 5. Global Amlodipine Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Amlodipine Sales Share by Manufacturers (2016-2021) Table 7. Global Amlodipine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Amlodipine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Amlodipine Average Price (US$/G) of Key Manufacturers (2016-2021) Table 10. Manufacturers Amlodipine Manufacturing Sites and Area Served Table 11. Manufacturers Amlodipine Product Type Table 12. Global Amlodipine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Amlodipine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amlodipine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Amlodipine Sales by Region (2016-2021) & (KG) Table 16. Global Amlodipine Sales Market Share by Region (2016-2021) Table 17. Global Amlodipine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Amlodipine Sales by Country (2016-2021) & (KG) Table 19. North America Amlodipine Sales Market Share by Country (2016-2021) Table 20. North America Amlodipine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Amlodipine Revenue Market Share by Country (2016-2021) Table 22. Europe Amlodipine Sales by Country (2016-2021) & (KG) Table 23. Europe Amlodipine Sales Market Share by Country (2016-2021) Table 24. Europe Amlodipine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Amlodipine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Amlodipine Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Amlodipine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Amlodipine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Amlodipine Revenue Market Share by Region (2016-2021) Table 30. Latin America Amlodipine Sales by Country (2016-2021) & (KG) Table 31. Latin America Amlodipine Sales Market Share by Country (2016-2021) Table 32. Latin America Amlodipine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Amlodipine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Amlodipine Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Amlodipine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Amlodipine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Amlodipine Revenue Market Share by Country (2016-2021) Table 38. Global Amlodipine Sales (KG) by Type (2016-2021) Table 39. Global Amlodipine Sales Market Share by Type (2016-2021) Table 40. Global Amlodipine Revenue (Million US$) by Type (2016-2021) Table 41. Global Amlodipine Revenue Share by Type (2016-2021) Table 42. Global Amlodipine Price (US$/G) by Type (2016-2021) Table 43. Global Amlodipine Sales (KG) by Application (2016-2021) Table 44. Global Amlodipine Sales Market Share by Application (2016-2021) Table 45. Global Amlodipine Revenue (Million US$) by Application (2016-2021) Table 46. Global Amlodipine Revenue Share by Application (2016-2021) Table 47. Global Amlodipine Price (US$/G) by Application (2016-2021) Table 48. Novartis Corporation Information Table 49. Novartis Description and Business Overview Table 50. Novartis Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 51. Novartis Amlodipine Product Table 52. Novartis Recent Developments/Updates Table 53. Pfizer Corporation Information Table 54. Pfizer Description and Business Overview Table 55. Pfizer Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 56. Pfizer Amlodipine Product Table 57. Pfizer Recent Developments/Updates Table 58. Lek Corporation Information Table 59. Lek Description and Business Overview Table 60. Lek Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 61. Lek Amlodipine Product Table 62. Lek Recent Developments/Updates Table 63. TEVA Corporation Information Table 64. TEVA Description and Business Overview Table 65. TEVA Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 66. TEVA Amlodipine Product Table 67. TEVA Recent Developments/Updates Table 68. Macleods Pharmaceuticals Corporation Information Table 69. Macleods Pharmaceuticals Description and Business Overview Table 70. Macleods Pharmaceuticals Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 71. Macleods Pharmaceuticals Amlodipine Product Table 72. Macleods Pharmaceuticals Recent Developments/Updates Table 73. Caraco Pharmaceutical Corporation Information Table 74. Caraco Pharmaceutical Description and Business Overview Table 75. Caraco Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 76. Caraco Pharmaceutical Amlodipine Product Table 77. Caraco Pharmaceutical Recent Developments/Updates Table 78. Sanis Health Corporation Information Table 79. Sanis Health Description and Business Overview Table 80. Sanis Health Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 81. Sanis Health Amlodipine Product Table 82. Sanis Health Recent Developments/Updates Table 83. Jamp Pharma Corporation Information Table 84. Jamp Pharma Description and Business Overview Table 85. Jamp Pharma Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 86. Jamp Pharma Amlodipine Product Table 87. Jamp Pharma Recent Developments/Updates Table 88. Accel Pharma Corporation Information Table 89. Accel Pharma Description and Business Overview Table 90. Accel Pharma Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 91. Accel Pharma Amlodipine Product Table 92. Accel Pharma Recent Developments/Updates Table 93. Jubilant Generics Corporation Information Table 94. Jubilant Generics Description and Business Overview Table 95. Jubilant Generics Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 96. Jubilant Generics Amlodipine Product Table 97. Jubilant Generics Recent Developments/Updates Table 98. Angita Pharma Corporation Information Table 99. Angita Pharma Description and Business Overview Table 100. Angita Pharma Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 101. Angita Pharma Amlodipine Product Table 102. Angita Pharma Recent Developments/Updates Table 103. Florida DOH Central Pharmacy Corporation Information Table 104. Florida DOH Central Pharmacy Description and Business Overview Table 105. Florida DOH Central Pharmacy Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 106. Florida DOH Central Pharmacy Amlodipine Product Table 107. Florida DOH Central Pharmacy Recent Developments/Updates Table 108. Shanghai Disainuo Biopharmaceutical Corporation Information Table 109. Shanghai Disainuo Biopharmaceutical Description and Business Overview Table 110. Shanghai Disainuo Biopharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 111. Shanghai Disainuo Biopharmaceutical Amlodipine Product Table 112. Shanghai Disainuo Biopharmaceutical Recent Developments/Updates Table 113. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Corporation Information Table 114. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Description and Business Overview Table 115. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 116. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Product Table 117. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Developments/Updates Table 118. Beijing Wansheng Pharmaceutical Corporation Information Table 119. Beijing Wansheng Pharmaceutical Description and Business Overview Table 120. Beijing Wansheng Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 121. Beijing Wansheng Pharmaceutical Amlodipine Product Table 122. Beijing Wansheng Pharmaceutical Recent Developments/Updates Table 123. Beijing Honglin Pharmaceutical Corporation Information Table 124. Beijing Honglin Pharmaceutical Description and Business Overview Table 125. Beijing Honglin Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 126. Beijing Honglin Pharmaceutical Amlodipine Product Table 127. Beijing Honglin Pharmaceutical Recent Developments/Updates Table 128. Beijing Maidihai Pharmaceutical Corporation Information Table 129. Beijing Maidihai Pharmaceutical Description and Business Overview Table 130. Beijing Maidihai Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 131. Beijing Maidihai Pharmaceutical Amlodipine Product Table 132. Beijing Maidihai Pharmaceutical Recent Developments/Updates Table 133. China Resources Saike Pharmaceutical Corporation Information Table 134. China Resources Saike Pharmaceutical Description and Business Overview Table 135. China Resources Saike Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 136. China Resources Saike Pharmaceutical Amlodipine Product Table 137. China Resources Saike Pharmaceutical Recent Developments/Updates Table 138. Beijing Jiulong Pharmaceutical Corporation Information Table 139. Beijing Jiulong Pharmaceutical Description and Business Overview Table 140. Beijing Jiulong Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 141. Beijing Jiulong Pharmaceutical Amlodipine Product Table 142. Beijing Jiulong Pharmaceutical Recent Developments/Updates Table 143. Tiannian Pharmaceutical Corporation Information Table 144. Tiannian Pharmaceutical Description and Business Overview Table 145. Tiannian Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 146. Tiannian Pharmaceutical Amlodipine Product Table 147. Tiannian Pharmaceutical Recent Developments/Updates Table 148. Chengdu Diao Pharmaceutical Group Corporation Information Table 149. Chengdu Diao Pharmaceutical Group Description and Business Overview Table 150. Chengdu Diao Pharmaceutical Group Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 151. Chengdu Diao Pharmaceutical Group Amlodipine Product Table 152. Chengdu Diao Pharmaceutical Group Recent Developments/Updates Table 153. Yangtze Pharmaceutical Corporation Information Table 154. Yangtze Pharmaceutical Description and Business Overview Table 155. Yangtze Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 156. Yangtze Pharmaceutical Amlodipine Product Table 157. Yangtze Pharmaceutical Recent Developments/Updates Table 158. Kunming Sino Pharmaceutical Corporation Information Table 159. Kunming Sino Pharmaceutical Description and Business Overview Table 160. Kunming Sino Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 161. Kunming Sino Pharmaceutical Amlodipine Product Table 162. Kunming Sino Pharmaceutical Recent Developments/Updates Table 163. Wuhan Dongxin Pharmaceutical Technology Corporation Information Table 164. Wuhan Dongxin Pharmaceutical Technology Description and Business Overview Table 165. Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 166. Wuhan Dongxin Pharmaceutical Technology Amlodipine Product Table 167. Wuhan Dongxin Pharmaceutical Technology Recent Developments/Updates Table 168. Jiangsu Wangao Pharmaceutical Corporation Information Table 169. Jiangsu Wangao Pharmaceutical Description and Business Overview Table 170. Jiangsu Wangao Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 171. Jiangsu Wangao Pharmaceutical Amlodipine Product Table 172. Jiangsu Wangao Pharmaceutical Recent Developments/Updates Table 173. Jiangsu Lianhuan Pharmaceutical Corporation Information Table 174. Jiangsu Lianhuan Pharmaceutical Description and Business Overview Table 175. Jiangsu Lianhuan Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 176. Jiangsu Lianhuan Pharmaceutical Amlodipine Product Table 177. Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates Table 178. Jiangsu Huanghe Pharmaceutical Corporation Information Table 179. Jiangsu Huanghe Pharmaceutical Description and Business Overview Table 180. Jiangsu Huanghe Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 181. Jiangsu Huanghe Pharmaceutical Amlodipine Product Table 182. Jiangsu Huanghe Pharmaceutical Recent Developments/Updates Table 183. Zhejiang Jingxin Pharmaceutical Corporation Information Table 184. Zhejiang Jingxin Pharmaceutical Description and Business Overview Table 185. Zhejiang Jingxin Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 186. Zhejiang Jingxin Pharmaceutical Amlodipine Product Table 187. Zhejiang Jingxin Pharmaceutical Recent Developments/Updates Table 188. Zhejiang Jianfeng Pharmaceutical Corporation Information Table 189. Zhejiang Jianfeng Pharmaceutical Description and Business Overview Table 190. Zhejiang Jianfeng Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 191. Zhejiang Jianfeng Pharmaceutical Amlodipine Product Table 192. Zhejiang Jianfeng Pharmaceutical Recent Developments/Updates Table 193. Hunan Qianjinxieli Pharmaceutical Corporation Information Table 194. Hunan Qianjinxieli Pharmaceutical Description and Business Overview Table 195. Hunan Qianjinxieli Pharmaceutical Amlodipine Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 196. Hunan Qianjinxieli Pharmaceutical Amlodipine Product Table 197. Hunan Qianjinxieli Pharmaceutical Recent Developments/Updates Table 198. Production Base and Market Concentration Rate of Raw Material Table 199. Key Suppliers of Raw Materials Table 200. Amlodipine Distributors List Table 201. Amlodipine Customers List Table 202. Amlodipine Market Trends Table 203. Amlodipine Growth Drivers Table 204. Amlodipine Market Restraints Table 205. Global Amlodipine Sales Forecast by Type (2022-2027) & (KG) Table 206. Global Amlodipine Sales Market Share Forecast by Type (2022-2027) Table 207. Global Amlodipine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 208. Global Amlodipine Revenue Market Share Forecast by Type (2022-2027) Table 209. Global Amlodipine Sales Forecast by Application (2022-2027) & (KG) Table 210. Global Amlodipine Sales Market Share Forecast by Application (2022-2027) Table 211. Global Amlodipine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 212. Global Amlodipine Revenue Market Share Forecast by Application (2022-2027) Table 213. Global Amlodipine Sales Forecast by Region (2022-2027) & (KG) Table 214. Global Amlodipine Sales Market Share Forecast by Region (2022-2027) Table 215. Global Amlodipine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 216. Global Amlodipine Revenue Market Share Forecast by Region (2022-2027) Table 217. Research Programs/Design for This Report Table 218. Key Data Information from Secondary Sources Table 219. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Amlodipine Figure 2. Global Amlodipine Market Share by Type in 2020 & 2027 Figure 3. Amlodipine Benzene Sulfonate Tablet Product Picture Figure 4. Amlodipine Mesylate Tablet Product Picture Figure 5. Levoamlodipine Maleic Acid Tablet Product Picture Figure 6. Global Amlodipine Market Share by Application in 2020 & 2027 Figure 7. High Blood Pressure Figure 8. Angina Pectoris Figure 9. Other Figure 10. Global Amlodipine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Amlodipine Market Size 2016-2027 (US$ Million) Figure 12. Global Amlodipine Sales 2016-2027 (KG) Figure 13. Global Amlodipine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Amlodipine Sales Share by Manufacturers in 2020 Figure 15. Global Amlodipine Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Amlodipine Players: Market Share by Revenue in 2020 Figure 17. Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Amlodipine Sales Market Share by Region (2016-2021) Figure 19. Global Amlodipine Sales Market Share by Region in 2020 Figure 20. Global Amlodipine Revenue Market Share by Region (2016-2021) Figure 21. Global Amlodipine Revenue Market Share by Region in 2020 Figure 22. U.S. Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. UAE Amlodipine Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Amlodipine by Type (2016-2021) Figure 47. Sales Market Share of Amlodipine by Application (2016-2021) Figure 48. Sales Market Share of Amlodipine by Application in 2020 Figure 49. Revenue Share of Amlodipine by Application (2016-2021) Figure 50. Revenue Share of Amlodipine by Application in 2020 Figure 51. Manufacturing Cost Structure of Amlodipine Figure 52. Manufacturing Process Analysis of Amlodipine Figure 53. Amlodipine Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us